Pharmacovigilance and Drug Safety Software

Global Market Trajectory & Analytics

MCP13964

EXECUTIVE ENGAGEMENTS

POOL

17839
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1784
Interactions with Platform & by Email

PARTICIPANTS

357
Unique # Participated

VALIDATIONS

91
Responses Validated*

COMPANIES

47
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

104

PAGES

181

EDITION

6

PRICE

USD 4950

CODE

MCP13964


COMPETITIVE METRICS

COMPANY

D S N T

% *

AB Cube

Accovion

APCER Life Sciences

Archimed Medical Communication

ArisGlobal LLC

Atlassian Pty., Ltd.

Basic Pharma

Biologit

Biomapas UAB

Bio-Trials

*Login to Participate & View Data Stacks
View 47 Companies...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Pharmacovigilance and Drug Safety Software estimated at US$143 Million in the year 2020, is projected to reach a revised size of US$201.8 Million by 2027, growing at a CAGR of 5.1% over the analysis period 2020-2027. ADR Reporting, one of the segments analyzed in the report, is projected to record a 4.5% CAGR and reach US$92 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Drug Safety Audits segment is readjusted to a revised 4.9% CAGR for the next 7-year period.
The Pharmacovigilance and Drug Safety Software market in the U.S. is estimated at US$42.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$35.7 Million by the year 2027 trailing a CAGR of 4.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.9% and 4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.
In the global Issue Tracking segment, USA, Canada, Japan, China and Europe will drive the 5.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$19.8 Million in the year 2020 will reach a projected size of US$28.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$23.3 Million by the year 2027.

SELECT PLAYERS

AB Cube; ArisGlobal LLC; Ennov USA; Extedo GmbH; Online Business Applications, Inc.; Oracle Corporation; Sarjen Systems Pvt. Ltd.; Sparta Systems, Inc.; United Biosource Corporation

SEGMENTS

» Deployment Model (On-premise, On-demand) » End-Use (Pharma & Biotech Companies, CROs, BPOs, Other End-Uses) » Functionality (ADR Reporting, Drug Safety Audits, Issue Tracking, Fully Integrated Software)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
World Current & Future Analysis for ADR Reporting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for ADR Reporting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Drug Safety Audits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Drug Safety Audits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Issue Tracking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Issue Tracking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Fully Integrated Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Fully Integrated Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for CROs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for BPOs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for BPOs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for On-premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for On-premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for On-demand by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for On-demand by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2020 & 2027
USA Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, CROs, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, CROs, BPOs and Other End-Uses for the Years 2020 & 2027
USA Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment Model - On-premise and On-demand - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment Model - Percentage Breakdown of Value Sales for On-premise and On-demand for the Years 2020 & 2027
CANADA
Canada Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2020 & 2027
Canada Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, CROs, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, CROs, BPOs and Other End-Uses for the Years 2020 & 2027
Canada Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment Model - On-premise and On-demand - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment Model - Percentage Breakdown of Value Sales for On-premise and On-demand for the Years 2020 & 2027
JAPAN
Japan Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2020 & 2027
Japan Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, CROs, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, CROs, BPOs and Other End-Uses for the Years 2020 & 2027
Japan Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment Model - On-premise and On-demand - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment Model - Percentage Breakdown of Value Sales for On-premise and On-demand for the Years 2020 & 2027
CHINA
China Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2020 & 2027
China Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, CROs, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, CROs, BPOs and Other End-Uses for the Years 2020 & 2027
China Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment Model - On-premise and On-demand - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment Model - Percentage Breakdown of Value Sales for On-premise and On-demand for the Years 2020 & 2027
EUROPE
Europe Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
Europe Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2020 & 2027
Europe Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, CROs, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, CROs, BPOs and Other End-Uses for the Years 2020 & 2027
Europe Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment Model - On-premise and On-demand - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment Model - Percentage Breakdown of Value Sales for On-premise and On-demand for the Years 2020 & 2027
FRANCE
France Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2020 & 2027
France Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, CROs, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, CROs, BPOs and Other End-Uses for the Years 2020 & 2027
France Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment Model - On-premise and On-demand - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment Model - Percentage Breakdown of Value Sales for On-premise and On-demand for the Years 2020 & 2027
GERMANY
Germany Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2020 & 2027
Germany Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, CROs, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, CROs, BPOs and Other End-Uses for the Years 2020 & 2027
Germany Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment Model - On-premise and On-demand - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment Model - Percentage Breakdown of Value Sales for On-premise and On-demand for the Years 2020 & 2027
ITALY
Italy Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2020 & 2027
Italy Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, CROs, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, CROs, BPOs and Other End-Uses for the Years 2020 & 2027
Italy Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment Model - On-premise and On-demand - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment Model - Percentage Breakdown of Value Sales for On-premise and On-demand for the Years 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2020 & 2027
UK Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, CROs, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, CROs, BPOs and Other End-Uses for the Years 2020 & 2027
UK Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment Model - On-premise and On-demand - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment Model - Percentage Breakdown of Value Sales for On-premise and On-demand for the Years 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2020 & 2027
Rest of Europe Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, CROs, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, CROs, BPOs and Other End-Uses for the Years 2020 & 2027
Rest of Europe Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment Model - On-premise and On-demand - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment Model - Percentage Breakdown of Value Sales for On-premise and On-demand for the Years 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, CROs, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, CROs, BPOs and Other End-Uses for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment Model - On-premise and On-demand - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment Model - Percentage Breakdown of Value Sales for On-premise and On-demand for the Years 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2020 & 2027
Rest of World Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, CROs, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, CROs, BPOs and Other End-Uses for the Years 2020 & 2027
Rest of World Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment Model - On-premise and On-demand - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment Model - Percentage Breakdown of Value Sales for On-premise and On-demand for the Years 2020 & 2027
Total Companies Profiled: 47

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com